PFIZER INC Quarterly Other Assets, Noncurrent in USD from Q4 2012 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Pfizer Inc quarterly Other Assets, Noncurrent history and growth rate from Q4 2012 to Q2 2024.
  • Pfizer Inc Other Assets, Noncurrent for the quarter ending June 30, 2024 was $10.7B, a 17.8% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $10.7B -$2.32B -17.8% Jun 30, 2024 10-Q 2024-08-05
Q1 2024 $11.2B -$1.77B -13.6% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $12.5B -$692M -5.26% Dec 31, 2023 10-Q 2024-08-05
Q3 2023 $8.81B -$2.08B -19.1% Oct 1, 2023 10-Q 2023-11-08
Q2 2023 $13B +$5.37B +70.1% Jul 2, 2023 10-Q 2023-08-09
Q1 2023 $13B +$5.09B +64.6% Apr 2, 2023 10-Q 2023-05-10
Q4 2022 $13.2B +$5.48B +71.4% Dec 31, 2022 10-K 2024-02-22
Q3 2022 $10.9B +$4.19B +62.4% Oct 2, 2022 10-Q 2022-11-09
Q2 2022 $7.66B +$1.6B +26.5% Jul 3, 2022 10-Q 2022-08-10
Q1 2022 $7.88B +$3.14B +66.1% Apr 3, 2022 10-Q 2022-05-11
Q4 2021 $7.68B +$2.8B +57.4% Dec 31, 2021 10-K 2023-02-23
Q3 2021 $6.71B +$2.35B +54% Oct 3, 2021 10-Q 2021-11-12
Q2 2021 $6.06B +$1.73B +40% Jul 4, 2021 10-Q 2021-08-12
Q1 2021 $4.74B +$578M +13.9% Apr 4, 2021 10-Q 2021-05-13
Q4 2020 $4.88B +$680M +16.2% Dec 31, 2020 10-K 2022-02-24
Q3 2020 $4.36B -$565M -11.5% Sep 27, 2020 10-Q 2020-11-05
Q2 2020 $4.33B -$61M -1.39% Jun 28, 2020 10-Q 2020-08-06
Q1 2020 $4.17B -$167M -3.85% Mar 29, 2020 10-Q 2020-05-07
Q4 2019 $4.2B +$1.4B +50% Dec 31, 2019 10-K 2021-02-25
Q3 2019 $4.92B +$1.94B +65.1% Sep 29, 2019 10-Q 2019-11-07
Q2 2019 $4.39B +$1.49B +51.5% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $4.33B +$1.44B +49.6% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $2.8B -$428M -13.3% Dec 31, 2018 10-K 2020-02-27
Q3 2018 $2.98B -$408M -12% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 $2.9B -$570M -16.4% Jul 1, 2018 10-Q 2018-08-09
Q1 2018 $2.9B -$433M -13% Apr 1, 2018 10-Q 2018-05-10
Q4 2017 $3.23B -$96M -2.89% Dec 31, 2017 10-K 2019-02-28
Q3 2017 $3.39B -$1.37B -28.8% Oct 1, 2017 10-Q 2017-11-09
Q2 2017 $3.47B -$1.15B -24.9% Jul 2, 2017 10-Q 2017-08-10
Q1 2017 $3.33B -$674M -16.8% Apr 2, 2017 10-Q 2017-05-11
Q4 2016 $3.32B -$97M -2.84% Dec 31, 2016 10-K 2018-02-22
Q3 2016 $4.76B +$848M +21.7% Oct 2, 2016 10-Q 2016-11-10
Q2 2016 $4.62B +$983M +27% Jul 3, 2016 10-Q 2016-08-11
Q1 2016 $4B +$287M +7.72% Apr 3, 2016 10-Q 2016-05-12
Q4 2015 $3.42B -$93M -2.65% Dec 31, 2015 10-K 2017-02-23
Q3 2015 $3.91B +$490M +14.3% Sep 27, 2015 10-Q 2015-11-05
Q2 2015 $3.64B +$61M +1.71% Jun 28, 2015 10-Q 2015-08-06
Q1 2015 $3.72B -$43M -1.14% Mar 29, 2015 10-Q 2015-05-07
Q4 2014 $3.51B -$83M -2.31% Dec 31, 2014 10-K 2016-02-29
Q3 2014 $3.42B Sep 28, 2014 10-Q 2014-11-06
Q2 2014 $3.57B Jun 29, 2014 10-Q 2014-08-07
Q1 2014 $3.76B Mar 30, 2014 10-Q 2014-05-08
Q4 2013 $3.6B +$363M +11.2% Dec 31, 2013 10-K 2015-02-27
Q4 2012 $3.23B Dec 31, 2012 10-K 2014-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.